IDH1 and central nervous system cancer: Importantly, the IDH1R132H mutation influenced the expression of the NAD-synthesis-associated enzyme NAMPT differently in the glioma cells and astrocytes, supporting the hypothesis that the IDH1 mutation differentially affects cells during tumorigenesis.